These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 17514662)

  • 81. Platelet function beyond hemostasis and thrombosis.
    Ware J; Corken A; Khetpal R
    Curr Opin Hematol; 2013 Sep; 20(5):451-6. PubMed ID: 23839296
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Platelet--cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation.
    Jurasz P; Alonso-Escolano D; Radomski MW
    Br J Pharmacol; 2004 Dec; 143(7):819-26. PubMed ID: 15492016
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Platelet proteomics and its advanced application for research of blood stasis syndrome and activated blood circulation herbs of Chinese medicine.
    Liu Y; Yin H; Chen K
    Sci China Life Sci; 2013 Nov; 56(11):1000-6. PubMed ID: 24114444
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Anti-platelet Drug-loaded Targeted Technologies for the Effective Treatment of Atherothrombosis.
    Muruganantham S; Krishnaswami V; Alagarsamy S; Kandasamy R
    Curr Drug Targets; 2021; 22(4):399-419. PubMed ID: 33109044
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Platelet dysfunction: a new dimension in inflammatory bowel disease.
    Collins CE; Rampton DS
    Gut; 1995 Jan; 36(1):5-8. PubMed ID: 7890235
    [No Abstract]   [Full Text] [Related]  

  • 86. Immune functions of platelets.
    Duerschmied D; Bode C; Ahrens I
    Thromb Haemost; 2014 Oct; 112(4):678-91. PubMed ID: 25209670
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Platelet activity in the pathophysiology of inflammatory bowel diseases.
    Chen C; Li Y; Yu Z; Liu Z; Shi Y; Lewandowska U; Sobczak M; Fichna J; Kreis M
    Curr Drug Targets; 2015; 16(3):219-25. PubMed ID: 25585124
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Nutrition, supplements, and vitamins in platelet function and bleeding.
    Violi F; Pignatelli P; Basili S
    Circulation; 2010 Mar; 121(8):1033-44. PubMed ID: 20194876
    [No Abstract]   [Full Text] [Related]  

  • 89. Pathophysiology 2: The Role of Platelets in Cancer Biology.
    Franco AT; Ware J
    Cancer Treat Res; 2019; 179():37-54. PubMed ID: 31317479
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Platelets and thrombolytic therapy.
    Coller BS
    N Engl J Med; 1990 Jan; 322(1):33-42. PubMed ID: 2264841
    [No Abstract]   [Full Text] [Related]  

  • 91. Platelet-targeted pharmacologic treatments as anti-cancer therapy.
    Gresele P; Momi S; Malvestiti M; Sebastiano M
    Cancer Metastasis Rev; 2017 Jun; 36(2):331-355. PubMed ID: 28707198
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Intravital Assessment of Blood Platelet Function. A Review of the Methodological Approaches with Examples of Studies of Selected Aspects of Blood Platelet Function.
    Polak D; Talar M; Watala C; Przygodzki T
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33172065
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Antiplatelet therapy in the prevention of coronary syndromes: mode of action, benefits, drawbacks.
    Picker SM
    Cardiovasc Hematol Agents Med Chem; 2013 Mar; 11(1):49-57. PubMed ID: 23157608
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Translational Implications of Platelets as Vascular First Responders.
    Becker RC; Sexton T; Smyth SS
    Circ Res; 2018 Feb; 122(3):506-522. PubMed ID: 29420211
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Platelets as mediators of inflammation.
    Steinhubl SR
    Hematol Oncol Clin North Am; 2007 Feb; 21(1):115-21. PubMed ID: 17258122
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Platelet-leukocyte interactions in inflammation and atherothrombosis.
    May AE; Langer H; Seizer P; Bigalke B; Lindemann S; Gawaz M
    Semin Thromb Hemost; 2007 Mar; 33(2):123-7. PubMed ID: 17340459
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A platelet-inspired paradigm for nanomedicine targeted to multiple diseases.
    Modery-Pawlowski CL; Kuo HH; Baldwin WM; Sen Gupta A
    Nanomedicine (Lond); 2013 Oct; 8(10):1709-27. PubMed ID: 24074391
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Platelet distention test. Study in malignant neoplasms].
    Spilotros G; Marasà L; Argano SA; Tomasino RM
    Recenti Prog Med; 1979 Apr; 66(4):427-36. PubMed ID: 482727
    [No Abstract]   [Full Text] [Related]  

  • 99. Platelet resistance to the anti-aggregating agents in the insulin resistant states.
    Anfossi G; Russo I; Trovati M
    Curr Diabetes Rev; 2006 Nov; 2(4):409-30. PubMed ID: 18220645
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Malignancy and haemostasis.
    Donati MB; Poggi A
    Br J Haematol; 1980 Feb; 44(2):173-82. PubMed ID: 6990959
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.